MeiraGTx Holdings (MGTX) Cash from Investing Activities Growth (1y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -122.45% |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 10.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.59% |
| Sep 30, 2025 | 58.37% |
| Jun 30, 2025 | 42.74% |
| Mar 31, 2025 | -106.25% |
| Dec 31, 2024 | -102.38% |
| Sep 30, 2024 | 63.13% |
| Jun 30, 2024 | 73.29% |
| Mar 31, 2024 | 417.72% |
| Dec 31, 2023 | 702.66% |
| Sep 30, 2023 | 64.40% |
| Jun 30, 2023 | 64.46% |
| Mar 31, 2023 | 30.94% |
| Dec 31, 2022 | 66.53% |
| Sep 30, 2022 | 15.91% |
| Jun 30, 2022 | -151.12% |
| Mar 31, 2022 | 33.96% |
| Dec 31, 2021 | -147.89% |
| Sep 30, 2021 | 39.98% |
| Jun 30, 2021 | -91.19% |
| Mar 31, 2021 | -367.49% |
| Dec 31, 2020 | -99.13% |
| Sep 30, 2020 | -880.06% |
| Jun 30, 2020 | -167.09% |
| Mar 31, 2020 | -261.90% |
| Dec 31, 2019 | 42.16% |
| Sep 30, 2019 | -91.90% |
| Jun 30, 2019 | -914.99% |
| Mar 31, 2019 | 7.87% |
| Dec 31, 2018 | -313.96% |
| Sep 30, 2018 | 82.61% |